Pathogenic variants (PVs) in BRCA2 are a major cause of hereditary breast and ovarian cancer (HBOC) syndrome, a condition characterized by a significantly increased risk of developing breast, ovarian, pancreatic, and prostate cancers [3]. Here, BRCA2 is linked to prostate cancer.